Assignee profile:

IMMUNOVACCINE TECHNOLOGIES, INC.

City:

Halifax

Country:

Canada

Published Applications:

9

Last publication date:

2018-10-11

Patent Grants:

7

Last grant date:

2020-08-04

Top Inventors for applications by IMMUNOVACCINE TECHNOLOGIES, INC.

These are the the leading inventors for applications assigned to IMMUNOVACCINE TECHNOLOGIES, INC.:

Recent patent applications by IMMUNOVACCINE TECHNOLOGIES, INC.

IMMUNOVACCINE TECHNOLOGIES, INC. based in Halifax, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-10-11 ✅ Patent 10,729,766 granted on 2020-08-04
US20180289801A1
Human necessities

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

#2 | 2018-06-28 ✅ Patent 10,272,042 granted on 2019-04-30
US20180177726A1
Human necessities

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

#3 | 2015-07-23 ✅ Patent 9,925,142 granted on 2018-03-27
US20150202152A1
Human necessities

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

#4 | 2014-04-10 ✅ Patent 9,114,174 granted on 2015-08-25
US20140099358A1
Human necessities

Vaccines with enhanced immune response and methods for their preparation

#5 | 2011-03-24
US20110070298A1
Human necessities

Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance

#6 | 2009-12-03
US20090297593A1
Human necessities

Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment

#7 | 2009-04-09 ✅ Patent 7,824,686 granted on 2010-11-02
US20090092666A1
Human necessities

Vaccines with enhanced immune response and methods for their preparation

#8 | 2009-03-19 ✅ Patent 8,628,937 granted on 2014-01-14
US20090074853A1
Human necessities

Vaccines with enhanced immune response and methods for their preparation

#9 | 2006-06-06 ✅ Patent 7,056,515 granted on 2006-06-06
US10636620
-

Antigens for immunocontraception

Also check out IMMUNOVACCINE TECHNOLOGIES, INC.'s (Halifax, Canada) applicant profile with 2 patent applications submitted.

AssigneeID:

60946 ⎘